XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
Quick Stats
Feb 02, 202652.0
AI Score
HOLD0.01
Volume Ratio
Dec 29, 2025
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
XTLB Stock Summary
Last updated Feb 02, 2026
XTLB is currently trading at $0.836, positioned below its 200-day moving average of $1.17, suggesting bearish momentum. The stock has a 52-week range of $0.5301 to $2.57.
Technical Analysis: The 50-day moving average stands at $0.82, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 47.709, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.025, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates XTLB at 52.0/100 with a HOLD recommendation.
XTLB (XTL Biopharmaceuticals Ltd. American Depositary Shares) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 47.709 |
| CMF (20) | 0.025 |
| ROC (10) | -15.325 |
| ADX (14) | 38.623 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.02 |
| AROONOSC (14) | 7.143 |
| WILLAMS %R (14) | -86.983 |
| MFI (14) | 95.391 |
XTLB Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
XTLB Price vs Max Options Open Interest
XTLB Max Change In Options Open Interest
XTLB Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XTLB Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XTLB Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XTLB Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
XTL Biopharmaceuticals Ltd. American Depositary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
XTLB Moving Averages Analysis
XTL Biopharmaceuticals Ltd. American Depositary Shares has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Feb 02, 2026
XTLB (XTL Biopharmaceuticals Ltd. American Depositary Shares) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 0.93 |
| 20 | 0.86 |
| 30 | 0.82 |
| 50 | 0.82 |
| 100 | 1.01 |
| 200 | 1.17 |
XTLB Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 8.1 million |
| Earnings/Share ($) | -0.9 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | 30 |
| Most Recent Quarter |